1.Asia-Pacific Menopause Federation Consensus Statement on the Management of Menopause 2024
Seng Bin ANG ; Stella Rizalina Sasha SUGIANTO ; Felicia Clara Jun Hui TAN ; Sonia DAVISON ; Qi YU ; Masakazu TERAUCHI ; Mee-Ran KIM ; Jignesh SHAH ; Shaikh Zinnat Ara NASREEN ; Choon Moy HO ; Enkhee SODNOMDORJ ; Muhammad Fidel Ganis SIREGAR ; Rubina HUSSAIN ; Ma Corazon Zaida NOBLEJAS-GAMILLA ; Yang CHUA ; Yung-Chieh TSAI ; Unnop JAISAMRARN
Journal of Menopausal Medicine 2025;31(1):3-11
Objectives:
This study aimed to achieve expert consensus on menopause management in the Asia-Pacific region, taking into account patient diversity, the latest evidence, and current treatment options.
Methods:
A focused literature search was performed to identify clinical practice statements on menopause management. Menopause experts were nominated by members of the Asia-Pacific Menopause Federation (APMF) society. A modified Delphi methodology, involving iterative rounds of anonymous surveys, was employed until consensus was reached for each statement. Consensus was defined as ≥ 70% of experts voting ‘agree’ or ‘strongly agree’ for a given clinical practice statement.
Results:
A total of 39 participants from 14 different APMF member societies were involved. Eighty-five clinical practice statements reached a consensus. Based on the clinical practice statements, an algorithm was created as a tool to guide clinicians on menopause management. APMF experts agreed that, in addition to vasomotor symptoms, Asian women experiencing somatic or psychological symptoms may also benefit from treatment with menopausal hormone therapy (MHT). MHT should also be considered for the prevention of osteoporosis in asymptomatic peri- and postmenopausal women.
Conclusions
This APMF consensus statement supersedes the previous one published in 2008. It provides guidance to gynecologists, endocrinologists, family physicians, and other healthcare professionals in delivering optimal care to menopausal women in the ethnically and culturally diverse Asia-Pacific region.
2.Asia-Pacific Menopause Federation Consensus Statement on the Management of Menopause 2024
Seng Bin ANG ; Stella Rizalina Sasha SUGIANTO ; Felicia Clara Jun Hui TAN ; Sonia DAVISON ; Qi YU ; Masakazu TERAUCHI ; Mee-Ran KIM ; Jignesh SHAH ; Shaikh Zinnat Ara NASREEN ; Choon Moy HO ; Enkhee SODNOMDORJ ; Muhammad Fidel Ganis SIREGAR ; Rubina HUSSAIN ; Ma Corazon Zaida NOBLEJAS-GAMILLA ; Yang CHUA ; Yung-Chieh TSAI ; Unnop JAISAMRARN
Journal of Menopausal Medicine 2025;31(1):3-11
Objectives:
This study aimed to achieve expert consensus on menopause management in the Asia-Pacific region, taking into account patient diversity, the latest evidence, and current treatment options.
Methods:
A focused literature search was performed to identify clinical practice statements on menopause management. Menopause experts were nominated by members of the Asia-Pacific Menopause Federation (APMF) society. A modified Delphi methodology, involving iterative rounds of anonymous surveys, was employed until consensus was reached for each statement. Consensus was defined as ≥ 70% of experts voting ‘agree’ or ‘strongly agree’ for a given clinical practice statement.
Results:
A total of 39 participants from 14 different APMF member societies were involved. Eighty-five clinical practice statements reached a consensus. Based on the clinical practice statements, an algorithm was created as a tool to guide clinicians on menopause management. APMF experts agreed that, in addition to vasomotor symptoms, Asian women experiencing somatic or psychological symptoms may also benefit from treatment with menopausal hormone therapy (MHT). MHT should also be considered for the prevention of osteoporosis in asymptomatic peri- and postmenopausal women.
Conclusions
This APMF consensus statement supersedes the previous one published in 2008. It provides guidance to gynecologists, endocrinologists, family physicians, and other healthcare professionals in delivering optimal care to menopausal women in the ethnically and culturally diverse Asia-Pacific region.
3.Asia-Pacific Menopause Federation Consensus Statement on the Management of Menopause 2024
Seng Bin ANG ; Stella Rizalina Sasha SUGIANTO ; Felicia Clara Jun Hui TAN ; Sonia DAVISON ; Qi YU ; Masakazu TERAUCHI ; Mee-Ran KIM ; Jignesh SHAH ; Shaikh Zinnat Ara NASREEN ; Choon Moy HO ; Enkhee SODNOMDORJ ; Muhammad Fidel Ganis SIREGAR ; Rubina HUSSAIN ; Ma Corazon Zaida NOBLEJAS-GAMILLA ; Yang CHUA ; Yung-Chieh TSAI ; Unnop JAISAMRARN
Journal of Menopausal Medicine 2025;31(1):3-11
Objectives:
This study aimed to achieve expert consensus on menopause management in the Asia-Pacific region, taking into account patient diversity, the latest evidence, and current treatment options.
Methods:
A focused literature search was performed to identify clinical practice statements on menopause management. Menopause experts were nominated by members of the Asia-Pacific Menopause Federation (APMF) society. A modified Delphi methodology, involving iterative rounds of anonymous surveys, was employed until consensus was reached for each statement. Consensus was defined as ≥ 70% of experts voting ‘agree’ or ‘strongly agree’ for a given clinical practice statement.
Results:
A total of 39 participants from 14 different APMF member societies were involved. Eighty-five clinical practice statements reached a consensus. Based on the clinical practice statements, an algorithm was created as a tool to guide clinicians on menopause management. APMF experts agreed that, in addition to vasomotor symptoms, Asian women experiencing somatic or psychological symptoms may also benefit from treatment with menopausal hormone therapy (MHT). MHT should also be considered for the prevention of osteoporosis in asymptomatic peri- and postmenopausal women.
Conclusions
This APMF consensus statement supersedes the previous one published in 2008. It provides guidance to gynecologists, endocrinologists, family physicians, and other healthcare professionals in delivering optimal care to menopausal women in the ethnically and culturally diverse Asia-Pacific region.
4.Response to “The Value of Non-Clinical Applications of Artificial Intelligence in Radiology Should Be Noted”
Nicole Kessa WEE ; Kim-Ann GIT ; Wen-Jeng LEE ; Gaurang RAVAL ; Aziz PATTOKHOV ; Evelyn Lai Ming HO ; Chamaree CHUAPETCHARASOPON ; Chuapetcharasopon TOMIYAMA ; Kwan Hoong NG ; Cher Heng TAN
Korean Journal of Radiology 2024;25(12):1102-1103
5.Response to “The Value of Non-Clinical Applications of Artificial Intelligence in Radiology Should Be Noted”
Nicole Kessa WEE ; Kim-Ann GIT ; Wen-Jeng LEE ; Gaurang RAVAL ; Aziz PATTOKHOV ; Evelyn Lai Ming HO ; Chamaree CHUAPETCHARASOPON ; Chuapetcharasopon TOMIYAMA ; Kwan Hoong NG ; Cher Heng TAN
Korean Journal of Radiology 2024;25(12):1102-1103
6.Response to “The Value of Non-Clinical Applications of Artificial Intelligence in Radiology Should Be Noted”
Nicole Kessa WEE ; Kim-Ann GIT ; Wen-Jeng LEE ; Gaurang RAVAL ; Aziz PATTOKHOV ; Evelyn Lai Ming HO ; Chamaree CHUAPETCHARASOPON ; Chuapetcharasopon TOMIYAMA ; Kwan Hoong NG ; Cher Heng TAN
Korean Journal of Radiology 2024;25(12):1102-1103
7.Genomics-driven derivatization of the bioactive fungal sesterterpenoid variecolin: Creation of an unnatural analogue with improved anticancer properties.
Dexiu YAN ; Jemma ARAKELYAN ; Teng WAN ; Ritvik RAINA ; Tsz Ki CHAN ; Dohyun AHN ; Vladimir KUSHNAREV ; Tsz Kiu CHEUNG ; Ho Ching CHAN ; Inseo CHOI ; Pui Yi HO ; Feijun HU ; Yujeong KIM ; Hill Lam LAU ; Ying Lo LAW ; Chi Seng LEUNG ; Chun Yin TONG ; Kai Kap WONG ; Wing Lam YIM ; Nikolay S KARNAUKHOV ; Richard Y C KONG ; Maria V BABAK ; Yudai MATSUDA
Acta Pharmaceutica Sinica B 2024;14(1):421-432
A biosynthetic gene cluster for the bioactive fungal sesterterpenoids variecolin ( 1) and variecolactone ( 2) was identified in Aspergillus aculeatus ATCC 16872. Heterologous production of 1 and 2 was achieved in Aspergillus oryzae by expressing the sesterterpene synthase VrcA and the cytochrome P450 VrcB. Intriguingly, the replacement of VrcB with homologous P450s from other fungal terpenoid pathways yielded three new variecolin analogues ( 5- 7). Analysis of the compounds' anticancer activity in vitro and in vivo revealed that although 5 and 1 had comparable activities, 5 was associated with significantly reduced toxic side effects in cancer-bearing mice, indicating its potentially broader therapeutic window. Our study describes the first tests of variecolin and its analogues in animals and demonstrates the utility of synthetic biology for creating molecules with improved biological activities.
8.A Study of Factors Affecting Quality of Life in Elderly:Based on the 8th Korean National Health and Nutrition Examination Survey
Journal of the Korean Society of Biological Therapies in Psychiatry 2024;30(3):69-75
Objectives:
We examined the factors influencing heath related quality of life among elderly in Korea.
Methods:
The subjects of this research were 1,342 elderly people aged 65 years or over in Korea. Health related quality of life was measured using EuroQol-5 dimension (EQ-5D), and depression was measured using Patient Health Questionnaire-9. Statistical differences among the EQ-5D index score was analyzed using analysis of covariance and logistic regression analysis based on sociodemographic characteristics, subjective health perception, stress perception degree and depression severity.
Results:
Depression severely reduced health related quality of life. General characteristics having significant influence on health related quality of life index score included gender, income, education, marital status, subjective health perception, stress perception degree and severity of depression.
Conclusions
Depression is associated with severe reduction of the health related quality of life on EQ-5D index score.Social attention and further study of depression will be needed for improving the health related quality of life among elderly with depression.
9.A Study of Factors Affecting Quality of Life in Elderly:Based on the 8th Korean National Health and Nutrition Examination Survey
Journal of the Korean Society of Biological Therapies in Psychiatry 2024;30(3):69-75
Objectives:
We examined the factors influencing heath related quality of life among elderly in Korea.
Methods:
The subjects of this research were 1,342 elderly people aged 65 years or over in Korea. Health related quality of life was measured using EuroQol-5 dimension (EQ-5D), and depression was measured using Patient Health Questionnaire-9. Statistical differences among the EQ-5D index score was analyzed using analysis of covariance and logistic regression analysis based on sociodemographic characteristics, subjective health perception, stress perception degree and depression severity.
Results:
Depression severely reduced health related quality of life. General characteristics having significant influence on health related quality of life index score included gender, income, education, marital status, subjective health perception, stress perception degree and severity of depression.
Conclusions
Depression is associated with severe reduction of the health related quality of life on EQ-5D index score.Social attention and further study of depression will be needed for improving the health related quality of life among elderly with depression.
10.Response to “The Value of Non-Clinical Applications of Artificial Intelligence in Radiology Should Be Noted”
Nicole Kessa WEE ; Kim-Ann GIT ; Wen-Jeng LEE ; Gaurang RAVAL ; Aziz PATTOKHOV ; Evelyn Lai Ming HO ; Chamaree CHUAPETCHARASOPON ; Chuapetcharasopon TOMIYAMA ; Kwan Hoong NG ; Cher Heng TAN
Korean Journal of Radiology 2024;25(12):1102-1103

Result Analysis
Print
Save
E-mail